| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10899301 | Cancer Letters | 2016 | 9 Pages |
Abstract
Leptin can sustain cancer progression in hypoxic environment and when mitochondrial respiration is impaired. Leptin signaling axis, including the new proposed intermediate SIRT1, could represent a new diagnostic and therapeutic target in prostate cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alessia Calgani, Simona Delle Monache, Patrizia Cesare, Carlo Vicentini, Mauro Bologna, Adriano Angelucci,